ArticleMaterials today. Bio2026

A sustained-release depot formulation of β-nicotinamide mononucleotide for alleviating chemotherapy-induced myelosuppression.

Bin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.